Actelion Files NDA for Macitentan – Analyst Blog

By | October 29, 2012

Switzerland-based Actelion ( ALIOF ) recently submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for the approval of its pulmonary arterial hypertension

Read More:
Actelion Files NDA for Macitentan – Analyst Blog